Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis. Diabetes Medicine Read More Michael BonarJanuary 30, 2019Cardiovascular efficacy, SGLT2, GLP-1RA, T2DM
